Clinically significant anemia in HIV-infected pregnant women in India is not a major barrier to zidovudine use for prevention of maternal-to-child transmission.
Sinha G, Choi TJ, Nayak U, Gupta A, Nair S, Gupte N, Bulakh PM, Sastry J, Deshmukh SD, Khandekar MM, Kulkarni V, Bhosale RA, Bharucha KE, Phadke MA, Kshirsagar AS, Bollinger RC; Maternal Infant Transmission Study in Pune, India.
Sinha G, et al. Among authors: sastry j.
J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):210-7. doi: 10.1097/QAI.0b013e3180556000.
J Acquir Immune Defic Syndr. 2007.
PMID: 17414927
Clinical Trial.